CHARLES SCHWAB INVESTMENT MANAGEMENT INC - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 116 filers reported holding DICE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.21 and the average weighting 1.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$12,347,349
+68.6%
265,763
+4.0%
0.00%
+100.0%
Q1 2023$7,321,565
-7.3%
255,552
+0.9%
0.00%
-33.3%
Q4 2022$7,902,242
+106.5%
253,277
+34.2%
0.00%
+200.0%
Q3 2022$3,827,000
+99.1%
188,676
+52.4%
0.00%0.0%
Q2 2022$1,922,000
+5.7%
123,805
+30.2%
0.00%0.0%
Q1 2022$1,819,000
-22.0%
95,081
+3.2%
0.00%0.0%
Q4 2021$2,333,00092,1440.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders